ClinicalTrials.govpublic full text
The Clinical Significance of Cellular Immune Adjuvant Therapy of Triple Negative Breast Cancer
triple negative breast neoplasms, cellular immune therapy, triple negative breast cancer, adjuvant therapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 800289
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.